gefitinib

Gefitinib (INN) (IPA: ) (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa.
See more at Wikipedia.org...

Gefitinib Warning - High-alert drug! Iressa Pharmacologic class: Epidermal growth factor receptor inhibitor Therapeutic class: Antineoplastic [more]Gefitinib - Community and Resources

[geh-FIT-in-ib]
A drug that is used to treat non-small cell lung cancer and is being studied in the treatment of other types of cancer. It belongs to the family of drugs called epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors. Also called ZD 1839.